FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088737112> ?p ?o ?g. }

• W2088737112 endingPage "298" @default.
• W2088737112 startingPage "288" @default.
• W2088737112 abstract "Pyridostigmine has a protective effect against organophosphate poisoning when given in a dosage of 30 mg three times daily causing 20-40% cholinesterase inhibition. To test its safety in the human neuromuscular system, a double-blind study on 35 subjects divided into two matched groups was performed. One group was treated with pyridostigmine in a dose of 30 mg three times daily and the other group was treated similarly with placebo, both for a 10-day period. The resultant average cholinesterase inhibition in the treatment group was 23%. Muscle strength and endurance were tested before, during (on the 8th day), and after treatment. Electrodiagnostic studies, including nerve conduction, electromyography, and response to repetitive stimulation, were carried out on four subjects of the treatment group and on two subjects of the placebo group, both before and during treatment (eighth day). Isometric handgrip strength, isokinetic elbow flexor, and extensor strength did not differ between groups as a result of the treatment. Knee flexor and extensor isokinetic strength showed a small (but statistically significant) trend to improve more during placebo treatment, whereas knee extensor endurance decreased slightly in the placebo group. Both these effects are probably due to large fluctuations in performance of the placebo group, whereas the treatment group performance was quite constant. They probably do not represent any adverse effect of pyridostigmine. No electrophysiological changes were found in any of the subjects during treatment. We conclude that pyridostigmine does not cause any significant neuromuscular effect in healthy subjects when taken in a dosage of 90 mg daily for 8 days, causing 20-30% inhibition of cholinesterase." @default.
• W2088737112 created "2016-06-24" @default.
• W2088737112 creator A5004052018 @default.
• W2088737112 creator A5008392074 @default.
• W2088737112 creator A5020282697 @default.
• W2088737112 creator A5023747985 @default.
• W2088737112 creator A5055808756 @default.
• W2088737112 creator A5055901690 @default.
• W2088737112 creator A5073621293 @default.
• W2088737112 creator A5090351193 @default.
• W2088737112 date "1991-02-01" @default.
• W2088737112 modified "2023-09-23" @default.
• W2088737112 title "The influence of pyridostigmine administration on human neuromuscular functions?Studies in healthy human subjects" @default.
• W2088737112 cites W1964183596 @default.
• W2088737112 cites W1966562013 @default.
• W2088737112 cites W1969054953 @default.
• W2088737112 cites W1994545047 @default.
• W2088737112 cites W2014930098 @default.
• W2088737112 cites W2017289642 @default.
• W2088737112 cites W2029138361 @default.
• W2088737112 cites W2045791927 @default.
• W2088737112 cites W2048411785 @default.
• W2088737112 cites W2048811655 @default.
• W2088737112 cites W2049953001 @default.
• W2088737112 cites W2053857770 @default.
• W2088737112 cites W2054794976 @default.
• W2088737112 cites W2064433369 @default.
• W2088737112 cites W2067100715 @default.
• W2088737112 cites W2068871458 @default.
• W2088737112 cites W2079187904 @default.
• W2088737112 cites W2088565863 @default.
• W2088737112 cites W2123921990 @default.
• W2088737112 cites W2125485217 @default.
• W2088737112 cites W2163308483 @default.
• W2088737112 cites W2165098778 @default.
• W2088737112 cites W2225328290 @default.
• W2088737112 cites W2315380771 @default.
• W2088737112 cites W2320125573 @default.
• W2088737112 cites W2418364213 @default.
• W2088737112 cites W2426897384 @default.
• W2088737112 cites W2992258017 @default.
• W2088737112 doi "https://doi.org/10.1016/0272-0590(91)90113-i" @default.
• W2088737112 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1647337" @default.
• W2088737112 hasPublicationYear "1991" @default.
• W2088737112 type Work @default.
• W2088737112 sameAs 2088737112 @default.
• W2088737112 citedByCount "22" @default.
• W2088737112 countsByYear W20887371122015 @default.
• W2088737112 countsByYear W20887371122018 @default.
• W2088737112 countsByYear W20887371122023 @default.
• W2088737112 crossrefType "journal-article" @default.
• W2088737112 hasAuthorship W2088737112A5004052018 @default.
• W2088737112 hasAuthorship W2088737112A5008392074 @default.
• W2088737112 hasAuthorship W2088737112A5020282697 @default.
• W2088737112 hasAuthorship W2088737112A5023747985 @default.
• W2088737112 hasAuthorship W2088737112A5055808756 @default.
• W2088737112 hasAuthorship W2088737112A5055901690 @default.
• W2088737112 hasAuthorship W2088737112A5073621293 @default.
• W2088737112 hasAuthorship W2088737112A5090351193 @default.
• W2088737112 hasConcept C103486182 @default.
• W2088737112 hasConcept C126322002 @default.
• W2088737112 hasConcept C142724271 @default.
• W2088737112 hasConcept C1862650 @default.
• W2088737112 hasConcept C197934379 @default.
• W2088737112 hasConcept C204787440 @default.
• W2088737112 hasConcept C206044474 @default.
• W2088737112 hasConcept C27081682 @default.
• W2088737112 hasConcept C2777433710 @default.
• W2088737112 hasConcept C2777515770 @default.
• W2088737112 hasConcept C2778105408 @default.
• W2088737112 hasConcept C2779901103 @default.
• W2088737112 hasConcept C2909465803 @default.
• W2088737112 hasConcept C2910532367 @default.
• W2088737112 hasConcept C3017583242 @default.
• W2088737112 hasConcept C31896038 @default.
• W2088737112 hasConcept C42219234 @default.
• W2088737112 hasConcept C71924100 @default.
• W2088737112 hasConcept C99508421 @default.
• W2088737112 hasConceptScore W2088737112C103486182 @default.
• W2088737112 hasConceptScore W2088737112C126322002 @default.
• W2088737112 hasConceptScore W2088737112C142724271 @default.
• W2088737112 hasConceptScore W2088737112C1862650 @default.
• W2088737112 hasConceptScore W2088737112C197934379 @default.
• W2088737112 hasConceptScore W2088737112C204787440 @default.
• W2088737112 hasConceptScore W2088737112C206044474 @default.
• W2088737112 hasConceptScore W2088737112C27081682 @default.
• W2088737112 hasConceptScore W2088737112C2777433710 @default.
• W2088737112 hasConceptScore W2088737112C2777515770 @default.
• W2088737112 hasConceptScore W2088737112C2778105408 @default.
• W2088737112 hasConceptScore W2088737112C2779901103 @default.
• W2088737112 hasConceptScore W2088737112C2909465803 @default.
• W2088737112 hasConceptScore W2088737112C2910532367 @default.
• W2088737112 hasConceptScore W2088737112C3017583242 @default.
• W2088737112 hasConceptScore W2088737112C31896038 @default.
• W2088737112 hasConceptScore W2088737112C42219234 @default.
• W2088737112 hasConceptScore W2088737112C71924100 @default.
• W2088737112 hasConceptScore W2088737112C99508421 @default.
• W2088737112 hasIssue "2" @default.

• next